{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T16:39:52Z","timestamp":1772815192569,"version":"3.50.1"},"reference-count":15,"publisher":"Elsevier BV","issue":"8241","license":[{"start":{"date-parts":[[1981,8,1]],"date-time":"1981-08-01T00:00:00Z","timestamp":365472000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet"],"published-print":{"date-parts":[[1981,8]]},"DOI":"10.1016\/s0140-6736(81)90523-7","type":"journal-article","created":{"date-parts":[[2004,5,22]],"date-time":"2004-05-22T03:30:49Z","timestamp":1085196649000},"page":"270-271","source":"Crossref","is-referenced-by-count":188,"title":["TREATMENT OF ULCERATIVE COLITIS WITH HIGH-DOSE 5-AMINOSALICYLIC ACID ENEMAS"],"prefix":"10.1016","volume":"318","author":[{"given":"M.","family":"Campieri","sequence":"first","affiliation":[]},{"given":"G.A.","family":"Lanfranchi","sequence":"additional","affiliation":[]},{"given":"G.","family":"Bazzocchi","sequence":"additional","affiliation":[]},{"given":"G.","family":"Franzin","sequence":"additional","affiliation":[]},{"given":"C.","family":"Brignola","sequence":"additional","affiliation":[]},{"given":"A.","family":"Battocchia","sequence":"additional","affiliation":[]},{"given":"F.","family":"Sarti","sequence":"additional","affiliation":[]},{"given":"G.","family":"Labo","sequence":"additional","affiliation":[]},{"given":"P.R.","family":"Dal Monte","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0140-6736(81)90523-7_BIB1","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0140-6736(62)92080-9","article-title":"Sulphasalazine and salicylazosulphadimidine in ulcerative colitis","volume":"i","author":"Baron","year":"1962","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(81)90523-7_BIB2","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1136\/gut.5.5.437","article-title":"Controlled trial of sulphasalazine in the treatment of ulcerative colitis","volume":"5","author":"Dick","year":"1964","journal-title":"Gut"},{"key":"10.1016\/S0140-6736(81)90523-7_BIB3","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0140-6736(65)90972-4","article-title":"Controlled trial of sulphasalazine in maintenance therapy for ulcerative colitis","volume":"i","author":"Misiewicz","year":"1965","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(81)90523-7_BIB4","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1136\/gut.14.12.923","article-title":"A controlled therapeutic trial of long-term maintenance treatment of ulcerative colitis with sulphasalazine (Salazopyrin)","volume":"14","author":"Dissanayake","year":"1973","journal-title":"Gut"},{"key":"10.1016\/S0140-6736(81)90523-7_BIB5","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/cpt1972134539","article-title":"Absorption, metabolism and excretion of salicylazosulfapyridine in man","volume":"13","author":"Schr\u00f6der","year":"1972","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/S0140-6736(81)90523-7_BIB6","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0016-5085(73)80035-6","article-title":"Distribution studies of salicylazosulfapyridine and its metabolites","volume":"64","author":"Peppercorn","year":"1973","journal-title":"Gastroenterology"},{"key":"10.1016\/S0140-6736(81)90523-7_BIB7","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1136\/gut.14.8.631","article-title":"The metabolism of salicylazosulphapyridine in ulcerative colitis","volume":"14","author":"Das","year":"1973","journal-title":"Gut"},{"key":"10.1016\/S0140-6736(81)90523-7_BIB8","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/S0140-6736(77)90831-5","article-title":"An experiment to determine the active therapeutic moiety of sulphasalazine","volume":"ii","author":"Azad Khan","year":"1977","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(81)90523-7_BIB9","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1136\/gut.21.7.632","article-title":"Effect of sulphapyridine, 5-aminosalicylic acid and placebo in patients with idiopathic proctitis: a study to determine the active therapeutic moiety of sulphasalazine","volume":"21","author":"van Hees","year":"1980","journal-title":"Gut"},{"key":"10.1016\/S0140-6736(81)90523-7_BIB10","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1136\/bmj.2.5104.1072","article-title":"Treatment of ulcerative colitis with local hydrocortisone hemisuccinate sodium. A report on a controlled therapeutic trial","volume":"ii","author":"Truelove","year":"1958","journal-title":"Br Med J"},{"key":"10.1016\/S0140-6736(81)90523-7_BIB11","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1136\/bmj.2.5104.1077","article-title":"Treatment of ulcerative colitis with topical hydrocortisone hemisuccinate sodium. A controlled trial employing restricted sequential analysis","volume":"ii","author":"Watkinson","year":"1958","journal-title":"Br Med J"},{"key":"10.1016\/S0140-6736(81)90523-7_BIB12","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1136\/bmj.1.4979.1315","article-title":"Biopsy studies in ulcerative colitis","volume":"i","author":"Truelove","year":"1956","journal-title":"Br Med J"},{"key":"10.1016\/S0140-6736(81)90523-7_BIB13","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1136\/bmj.1.5220.147","article-title":"Medical management of ulcerative colitis","volume":"i","author":"Watkinson","year":"1961","journal-title":"Br Med J"},{"key":"10.1016\/S0140-6736(81)90523-7_BIB14","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000202190","article-title":"Topical steroid therapy of ulcerative colitis","volume":"103","author":"Patterson","year":"1965","journal-title":"Gastroenterologia (Basel)"},{"key":"10.1016\/S0140-6736(81)90523-7_BIB15","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1136\/gut.21.3.232","article-title":"Optimum dose of sulphasalazine for maintenance treatment in ulcerative colitis","volume":"21","author":"Azad Khan","year":"1981","journal-title":"Gut"}],"container-title":["The Lancet"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0140673681905237?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0140673681905237?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T07:11:10Z","timestamp":1585811470000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0140673681905237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1981,8]]},"references-count":15,"journal-issue":{"issue":"8241","published-print":{"date-parts":[[1981,8]]}},"alternative-id":["S0140673681905237"],"URL":"https:\/\/doi.org\/10.1016\/s0140-6736(81)90523-7","relation":{},"ISSN":["0140-6736"],"issn-type":[{"value":"0140-6736","type":"print"}],"subject":[],"published":{"date-parts":[[1981,8]]}}}